Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Related Articles by Review for PubMed (Select 21099110)

1.

The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.

Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, Thangavel C, Morrissey C, Zhang X, Comstock CE, Witkiewicz AK, Gomella L, Knudsen ES, Nelson PS, Knudsen KE.

J Clin Invest. 2010 Dec;120(12):4478-92. doi: 10.1172/JCI44239. Epub 2010 Nov 22.

2.

The role of tumor suppressor dysregulation in prostate cancer progression.

Dean JL, Knudsen KE.

Curr Drug Targets. 2013 Apr;14(4):460-71. Review.

PMID:
23410128
3.

Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer.

Knudsen KE, Penning TM.

Trends Endocrinol Metab. 2010 May;21(5):315-24. doi: 10.1016/j.tem.2010.01.002. Epub 2010 Feb 6. Review.

4.

Androgen action in the prostate gland.

Yadav N, Heemers HV.

Minerva Urol Nefrol. 2012 Mar;64(1):35-49. Review.

PMID:
22402316
5.

Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.

Shiota M, Yokomizo A, Naito S.

Free Radic Biol Med. 2011 Oct 1;51(7):1320-8. doi: 10.1016/j.freeradbiomed.2011.07.011. Epub 2011 Jul 23. Review.

PMID:
21820046
6.

Androgen receptor footprint on the way to prostate cancer progression.

Hodgson MC, Bowden WA, Agoulnik IU.

World J Urol. 2012 Jun;30(3):279-85. doi: 10.1007/s00345-011-0743-7. Epub 2011 Sep 17. Review.

7.

AR, the cell cycle, and prostate cancer.

Balk SP, Knudsen KE.

Nucl Recept Signal. 2008 Feb 1;6:e001. doi: 10.1621/nrs.06001. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk